Depressive state associated with cryptogenic rigid person syndrome (case study)

The article describes peculiarities of modern understanding of the nature and treatment of the rigid person syndrome. Baclofen, a GABA-B agonist, is one of the drugs of choice for the treatment of this condition. However, its oral use has little efficacy and leads to a number of complications. An indisputable alternative to oral administration of the drug at present is its continuous intrathecal administration using an implantable pump. A case of cryptogenic rigidity syndrome accompanied by the development of a depressive state is presented. In the process of treatment by intrathecal baclofen therapy, not only excruciating muscle spasms disappeared, but also depressive symptomatology without special use of antidepressants.

The purpose of the study. To show the high effectiveness of ITT in a patient with a severe cryptogenic form of CRS, as well as the effect of OT, not only on spasticity, but also on depressive symptoms.

Material and methods. A case of treatment by the ITB method with implantation of a pump to a patient with a cryptogenic form of HPV is presented. A modified Ashworth scale (MAS) was used to assess spasticity. The patient’s quality of life was assessed on the Barthel scale. The Hamilton scale was used to assess the level of depression.

1. Gorelik EYu, Skriplenko NV, Lapin SV, Vil’nic AA, Skripchenko EYu, Astapova AV, Marchenko NV, Vojtenkov VB, Moshnikova AN. Autoimmune encephalitis associated with glutamic acid decarboxylase antibodies in children. Prakticheskaya medicina. 2020;18(3):75–81. (In Russ.).

2. Enkoyan KB. Insights into neuronal survival processes. Medicine science and education: Yerevan. 2010;5:3–6. (In Russ.).

3. Krasnov MYu, Pavlov EV, Ershova MV, Timerbaeva SL, Illarioshkin SN. The range of neurological syndromes associated with glutamic acid decarboxylase antibodies. Klinicheskaya nevrologiya. 2015;9(4):37–41. (In Russ.).

4. Mal’mberg SA, Dadali EL, Zhumahanov DB, Dzhaksybaeva AH. Stiff-person syndrome with early onset in infancy. Nervno-myshechnye bolezni. 2015;2:38–43. (In Russ.).

5. Morozov IN, Slavin KV. Intrathecal Baclofen Therapy in Russia: National Register of Spastic States. Sovremennye tekhnologii v medicine. 2018;10(4):159 — 163. (In Russ.).

6. Murashko AA. Mental disorders in autoimmune encephalitidies. Social’naya i klinicheskaya psihiatriya. 2021;31(1):74–79. (In Russ.).

7. Nuzhnyj EP, Krasnov MYu, Ahmadullina DR, Abramova AA, Fedotova EYu, Illarioshkin SN. Ataxia associated with anti-glutamic acid decarboxylase antibodies. Nevrologiya, nejropsihiatriya, psihosomatika. 2020;12(5):66–70. (In Russ.).

8. Serdyuk AV, Kovrazhkina EA. The syndrome of a rigid person with myoclonus and disautonomy: a description of the case. Consilium Medicum. 2017;19(9):65–68. (In Russ.).

9. Sozaeva LS, Zil’berman LI, Svetlova GN et al.. Clinical and immunological characteristics of diabetes mellitus in patients with autoimmune polyglandular syndrome type 1 in Russia. Saharnyj diabet. 2018;21(1):48 — 57. (In Russ.).

10. Sorokina EA, El’chaninov DV, Plotnikova AV, Klimova IB, El’chaninova SA, Smagina IV. Stiff person syndrome. Nevrologicheskij zhurnal. 2018;4:195– 200. (In Russ.).

11. Dalakas M. Stiff person syndrome: advances in pathogenesis and therapeutic interventions. Curr. Treat. OptionsNeurol. 2009;11:102–107. Sarva H, Deik A, Ullah A, Severt W. Clinical spectrum of stiff person syndrome: a review of recent reports. Tremor Other Hyperkinet. Mov. 2016;6:1–23.